# Intrahepatic Chemotherapy to Patients With Non-resectable Liver Metastases From Solid Tumor

> **NCT01511146** · PHASE2 · UNKNOWN · sponsor: **Copenhagen University Hospital at Herlev** · enrollment: 100 (estimated)

## Conditions studied

- Liver Metastasis

## Interventions

- **DRUG:** Oxaliplatin
- **DRUG:** Mitomycin + Gemcitabine

## Key facts

- **NCT ID:** NCT01511146
- **Lead sponsor:** Copenhagen University Hospital at Herlev
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-07
- **Primary completion:** 2015-07
- **Final completion:** 2016-07
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2012-01-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01511146

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01511146, "Intrahepatic Chemotherapy to Patients With Non-resectable Liver Metastases From Solid Tumor". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01511146. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*